Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Back

Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:17   Issue: 9
Pp: 767-767
Massimo Breccia
DOI: 10.2174/156800961709171005155724



Editorial: Multiple Myeloma Immunotherapies free to download

Volume:17   Issue: 9
Pp: 768-768
Klaus Podar
DOI: 10.2174/156800961709171005160041



Stem Cell Transplantation in Multiple Myeloma

Volume:17   Issue: 9
Pp: 769-781
Massimo Offidani, Silvia Gentili, Francesca Gay, Elena Aghemo, Laura Maracci, Laura Corvatta and Antonio Palumbo*
DOI: 10.2174/1568009616666160920090236




Multiple Myeloma and the Immune Microenvironment

Volume:17   Issue: 9
Pp: 806-818
Yawara Kawano, Aldo. M. Roccaro, Irene M. Ghobrial* and Jamil Azzi*
DOI: 10.2174/1568009617666170214102301




Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment

Volume:17   Issue: 9
Pp: 819-838
Cirino Botta, Maria Cuce, Daniele Caracciolo, Lucia Fiorillo, Pierosandro Tagliaferri and Pierfrancesco Tassone*
DOI: 10.2174/1568009617666170330154756




Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma

Volume:17   Issue: 9
Pp: 839-845
Djordje Atanackovic, Tim Luetkens, Sabari Radhakrishnan and Nicolaus Kroger*
DOI: 10.2174/1568009617666170906170348




Immunomodulatory Drugs (IMiDs) in Multiple Myeloma

Volume:17   Issue: 9
Pp: 846-857
Shahzad Raza, Rachael A. Safyan and Suzanne Lentzsch*
DOI: 10.2174/1568009617666170214104426




Acknowledgements to Reviewers free to download

Volume:17   Issue: 9
Pp: 858-859

DOI: 10.2174/156800961709171005170117